Photocure renegotiates HexVix licence: GE out, Ipsen in
Photocure has put together a new commercial strategy for HexVix (hexaminolevulinate hydrochloride), its flagship product which helps in the diagnosis and resection of bladder cancer.
Photocure has put together a new commercial strategy for HexVix (hexaminolevulinate hydrochloride), its flagship product which helps in the diagnosis and resection of bladder cancer.